C-RAD announces reaching order intake, for an amount of approximately 10 MSEK, in South Korean territory.

The total order has a value of approximately 10 MSEK for C-RAD, includes SGRT systems, to be supplied to multiple Radiation Therapy institutions in South Korea. Delivery and installation are expected to commence in the first half of 2024.

“We are pleased with reaching this milestone in South Korea and are thankful for the trust our customers continue to place in C-RAD’s SGRT technology. We are committed to advancing patient-centric innovations and increasing safety through the whole radiation therapy workflow.” said Cecilia de Leeuw, CEO and President of C-RAD AB.

Receiving this order strengthens C-RAD's presence in South Korea and confirms that SGRT is being acknowledged as a key technology to enhance radiation therapy treatment outcomes on a global scale. 

For further information:

Cecilia de Leeuw, CEO, +46 (0)795 85 66 77, investors@c-rad.com
Christoffer Herou, CFO, +46 (0)725 82 86 16, investors@c-rad.com

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

Attachments

C-RAD expands its presence in South Korea, soon supplying multiple centers with SGRT systems

© Modular Finance, source Nordic Press Releases